WuXiHigh platform
Search documents
药明生物-演示文稿:新增信息要点
2026-01-13 02:11
M Update Updated Company Presentation – What's Incremental As preparation for a broker conference in the US, WuXi Bio updated its company presentation with new financial and operational metrics. The new disclosures were mostly qualitative. We highlight what's incremental. 1. The company is on track to deliver a strong 2025, both in top and bottom lines. Its 2025 guidance was 14-16% revenue growth, with improved profitability (note). 2. It continues to see "accelerated growth in FY26", supported by strong re ...